Five plus five equals nine
Release time:
2023-06-07
Xiao Chen works in a construction company. Recently, a fruit stall appeared at the gate of the community where he lived. The owner of the stall was a woman with a girl. The girl was not big and looked like she was three or four years old.
Because her fruit is cheap, Xiao Chen often patronizes her. After going there many times, I became acquainted with the mother and daughter, especially the little girl, who was lively and lovely and very likable. There is only one thing that makes Xiao Chen strange. The weather is not cold, but the girl always wears a pair of pink gloves embroidered with Mickey Mouse. Strange to strange, Xiao Chen did not ask more.
Once Xiao Chen was choosing fruit when he heard the woman ask the child, "How much is five plus five?" The girl replied, "Nine."
Many people have the characteristics of being good teachers, so Xiao Chen opened his hands to the girl and said, "Look, little friend, five plus five equals..." Before
was finished, the girl's mother interrupted: "The answer is correct, baby is great!"
The mother's praise for a wrong answer puzzled Xiao Chen, which also troubled Xiao Chen for a long time.
One day at noon, Chen passed by the fruit stand and found only the girl sitting on the bench playing with the stuffed bear. Chen moved in his heart and went over to crouch down and asked the girl the same question: "Do you know how much five plus five equals, kid?"
The girl looked at Chen with clear eyes and answered confidently, "Nine."
Xiao Chen gently picked up her hands and said with a smile: "Look, each hand has five fingers, counting from left to right, one, two, three, four, five, six, seven, eight, nine..."
Suddenly Xiao Chen froze because the last finger cot he pinched was empty.
Xiao Chen wait for a while looked up at the girl, and her crisp voice came from her ear: "It is equal to nine, my mother taught me."
Holding her empty finger cot, Xiao Chen understood something in an instant. After a few seconds of silence, Xiao Chen squeezed out a smile again, patted her on the shoulder and said, "Yes, it is equal to nine. My mother taught me right."
When he got up, Xiao Chen had mixed feelings.
For this mother and daughter, five plus five equals nine may be the wrong answer, but it cannot be more correct. (Ye Yujing)
Tutor Comments (Xu Shuifa, member of Zhejiang Writers Association, writer of short stories):
After reading this article, I felt a little heavy, for the little girl in the article and also for the author. The article story is complete, the context is clear, the language is fluent, obviously the author's writing skills are good. Just as a short novel, it feels like something is missing. Looking back, when I saw that "the girl always wears a pair of pink gloves embroidered with Mickey Mouse", I immediately thought that there should be something wrong with the girl's hand. When I think about the problem again, I understand that the girl's finger should be missing. One, sure enough, this is the result behind. The novel needs to use various methods such as foreshadowing and foreshadowing, which makes the plot become ups and downs and fascinating. If it is not done well, it may backfire.
The theme of the full text is questionable. In order to protect the child's young mind from harm, the mother will make mistakes, even "Xiao Chen" is the default. As the child grows up, how long will this white lie last, and in case it doesn't last long, won't the child still be hurt? Therefore, it is suggested that the author let the story continue to develop and design some special plot, and the final result let the child know that it is just a different kind of love for the mother, and understand that "five plus five equals nine" is just a white lie. In this way, the problem of article education orientation is also solved.
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31